Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

Researchers at the University of Gothenburg have identified a protein linked to an increased risk of metastasis and recurrence in lung cancer. The findings are presented in a study that paves the way ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

Women with de novo metastatic breast cancer that is confined to a single distant organ may live longer when they undergo resection of the primary tumor, a large cohort study suggested. The study, of ...

Dr. Will Parsons, of Texas Children’s, discusses evolving therapies, survivorship clinics and tools like Passport For Care for long-term cancer care. For a child diagnosed with cancer, cure is the ...

Particle therapy is revolutionizing radiation oncology by enabling highly precise, individualized cancer treatments. As technology evolves, the integration ...

A woman has filed suit against a UVA School of Medicine professor alleging he carried out a “non-standard third round of ...

Wellstar West Georgia installs a second Varian TrueBeam system in LaGrange, expanding precise radiation therapy and cutting ...

Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...

At the 2026 Miami Breast Cancer Conference, Kevin Kalinsky, MD, MS, participated in a molecular tumor board session that brought together a multidisciplinary panel including medic ...

Roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point. It's the most common cancer in women, excluding skin cancers.

Thirty-six progressive mCRPC patients received TLX591-Tx across three cohorts (enzalutamide, abiraterone, or docetaxel sequence), and all completed two planned doses without emergent, unexpected ...